Cargando…
High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
BACKGROUND: Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018440/ https://www.ncbi.nlm.nih.gov/pubmed/21162751 http://dx.doi.org/10.1186/1756-3305-3-120 |
_version_ | 1782196067681435648 |
---|---|
author | Hodges, Mary H Smith, Samuel J Fussum, Daniel Koroma, Joseph B Conteh, Abdul Sonnie, Mustapha Sesay, Santigie Zhang, Yaobi |
author_facet | Hodges, Mary H Smith, Samuel J Fussum, Daniel Koroma, Joseph B Conteh, Abdul Sonnie, Mustapha Sesay, Santigie Zhang, Yaobi |
author_sort | Hodges, Mary H |
collection | PubMed |
description | BACKGROUND: Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent children from becoming infected. This level of coverage has been a challenge in urban settings. Assessing the coverage in a rapidly growing urban/non-rural setting with inadequate population data is also problematic. In Sierra Leone, a 5-day preventative chemotherapy campaign was carried out in the Western Area including the capital: Freetown. An intensive, social mobilization strategy combined traditional and modern communication channels. To aid dissemination of appropriate information Frequently Asked Questions were developed and widely circulated. The population of the Western Area has grown faster than projected by the 2004 National Census due to the post-war settlement of internally displaced persons. As a reliable denominator was not available, independent monitoring was adapted and performed "in process" to aid program performance and "end process" to assess final coverage. RESULTS: In 5 days 1,104,407 eligible persons were treated. Using the projected population from the 2004 census this figure represented coverage of 116% in the Urban Western Area and 129% in the Rural Western Area. Independent monitors interviewed a total of 9,253 persons during the 2 End Process days representing 1% of the projected population. Of these, 85.8% recalled taking both ivermectin and albendazole (Urban: 85.2%, Rural: 87.1%). No serious adverse drug reactions were reported. CONCLUSION: The paper presents the key elements of success of the social mobilization and implementation strategy and describes the independent monitoring used to estimate final coverage in this urban/non-rural setting where the current population size is uncertain. This implementation strategy and Independent Monitoring tool could be useful in similar, rapidly growing cities implementing lymphatic filariasis elimination programs. |
format | Text |
id | pubmed-3018440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30184402011-01-11 High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone Hodges, Mary H Smith, Samuel J Fussum, Daniel Koroma, Joseph B Conteh, Abdul Sonnie, Mustapha Sesay, Santigie Zhang, Yaobi Parasit Vectors Research BACKGROUND: Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent children from becoming infected. This level of coverage has been a challenge in urban settings. Assessing the coverage in a rapidly growing urban/non-rural setting with inadequate population data is also problematic. In Sierra Leone, a 5-day preventative chemotherapy campaign was carried out in the Western Area including the capital: Freetown. An intensive, social mobilization strategy combined traditional and modern communication channels. To aid dissemination of appropriate information Frequently Asked Questions were developed and widely circulated. The population of the Western Area has grown faster than projected by the 2004 National Census due to the post-war settlement of internally displaced persons. As a reliable denominator was not available, independent monitoring was adapted and performed "in process" to aid program performance and "end process" to assess final coverage. RESULTS: In 5 days 1,104,407 eligible persons were treated. Using the projected population from the 2004 census this figure represented coverage of 116% in the Urban Western Area and 129% in the Rural Western Area. Independent monitors interviewed a total of 9,253 persons during the 2 End Process days representing 1% of the projected population. Of these, 85.8% recalled taking both ivermectin and albendazole (Urban: 85.2%, Rural: 87.1%). No serious adverse drug reactions were reported. CONCLUSION: The paper presents the key elements of success of the social mobilization and implementation strategy and describes the independent monitoring used to estimate final coverage in this urban/non-rural setting where the current population size is uncertain. This implementation strategy and Independent Monitoring tool could be useful in similar, rapidly growing cities implementing lymphatic filariasis elimination programs. BioMed Central 2010-12-16 /pmc/articles/PMC3018440/ /pubmed/21162751 http://dx.doi.org/10.1186/1756-3305-3-120 Text en Copyright ©2010 Hodges et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hodges, Mary H Smith, Samuel J Fussum, Daniel Koroma, Joseph B Conteh, Abdul Sonnie, Mustapha Sesay, Santigie Zhang, Yaobi High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone |
title | High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone |
title_full | High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone |
title_fullStr | High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone |
title_full_unstemmed | High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone |
title_short | High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone |
title_sort | high coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the western area, sierra leone |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018440/ https://www.ncbi.nlm.nih.gov/pubmed/21162751 http://dx.doi.org/10.1186/1756-3305-3-120 |
work_keys_str_mv | AT hodgesmaryh highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone AT smithsamuelj highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone AT fussumdaniel highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone AT koromajosephb highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone AT contehabdul highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone AT sonniemustapha highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone AT sesaysantigie highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone AT zhangyaobi highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone |